Fusheng Q. Zhang

Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

TMED9 drives non-small-cell lung cancer progression via promotion of autophagy by recruiting USP5 to deubiquitinate ATG9A.

TMED9 drives non-small-cell lung cancer progression via promotion of autophagy by recruiting USP5 to deubiquitinate ATG9A.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 02, 2026

Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy.

Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy.

Journal: iScience

Published: June 15, 2026

Exosomal miR-4644 Targets SPRY3 to Promote Proliferation and Invasion of Pancreatic Cancer.

Exosomal miR-4644 Targets SPRY3 to Promote Proliferation and Invasion of Pancreatic Cancer.

Journal: Cancer medicine

Published: March 08, 2026

The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver Metastasis.

The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver Metastasis.

Journal: International journal of biological sciences

Published: February 06, 2026

Diagnosis and treatment of infective endocarditis in patient with Fabry disease: a case report

Diagnosis and treatment of infective endocarditis in patient with Fabry disease: a case report

Journal: Zhonghua nei ke za zhi

Published: February 03, 2026

Multi-omics analysis of polyamine metabolism implicates NT5E/CD73 in the progression of pancreatic cancer.

Multi-omics analysis of polyamine metabolism implicates NT5E/CD73 in the progression of pancreatic cancer.

Journal: Cancer letters

Published: April 12, 2025

Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer.

Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer.

Journal: Journal of Cancer

Published: December 27, 2024

Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer.

Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer.

Journal: Journal of translational medicine

Published: August 30, 2024

Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation.

Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation.

Journal: Cancer letters

Published: July 21, 2024

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.

Journal: Journal of hematology & oncology

Published: June 25, 2024

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.

Journal: Cancer communications (London, England)

Published: November 26, 2023

Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer.

Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer.

Journal: Aging

Published: July 17, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026